Skip to main content
Log in

Improve Solubility of Acetamidophenol from PEG and Witepsol Suppositories via Formation of Inclusion Complex by β-Cyclodextrin with a Controlled Release Profile

  • Original Article
  • Published:
Journal of Pharmaceutical Innovation Aims and scope Submit manuscript

Abstract

Purpose

Acetamidophenol (ACP) is used to treat mild to moderate pain and reduce fever, but low water solubility and poorly dissolution of this compound restricted its bioavailability.

Methods

To overcome these problems and enhance the solubility of ACP, inclusion complex between ACP and β-cyclodextrin (β-CD) is formed with various mass ratios of β-CD:ACP (1:1, 1:2, 1:4, 1:8), and the effect of complex formation on solubility and release of ACP from PEG and Witepsol-based suppositories through rectal route of administration is investigated.

Results

Inclusion complexes formed with various ratios of β-CD:ACP and loaded in the formulation of suppositories by fusion method utilizing different suppository bases, i.e., Witepsol H15 and polyethylene glycol (4000, 400). FTIR, SEM, and XRD results indicate formation of inclusion complex between β-CD and ACP. Physical characteristics and in vitro drug release of the obtained suppositories are determined by several tests such as weight variation, melting point, hardness, and release rate.

Conclusion

Results indicate that PEG-based suppositories containing β-CD:ACP 1:1 mass ratio show the best in vitro drug release characteristic which released 19.3% of ACP after 8 h.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. David SJ. Pharmaceutics dosage form and design, 2nd edition, chapter 4; 2016:4–7.

  2. Jahromi MM, Ghaemi H, Tafti MA, Arabzadeh A, Afsharypuor S. Vaginal and rectal dosage forms in Iranian traditional pharmacy. J Nat Pharm Prod. 2015;10:1–3.

    Google Scholar 

  3. Schrewsbury R. Applied pharmaceutics in contemporary compounding, 3rd edition, 2015.

  4. Baviskara P, Bedsea A, Sadiqueb S, Kundea V, Jaiswal S. Drug delivery on rectal absorption: suppositories. Int J Pharm Sci Rev Res. 2013;13:70–6.

    Google Scholar 

  5. El-Majri MA, El-Basir MM. Formulation and evaluation of ibuprofen suppositories. J Res Pharm Pract. 2016;7:87–90.

    CAS  Google Scholar 

  6. Bibby DC, Davies NM, Tucker IG. Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. Int J Pharm. 2000;197:1–11.

    Article  CAS  PubMed  Google Scholar 

  7. Demirel M, Yurtdas G, Genc L. Inclusion complexes of ketoconazole with beta-cyclodextrin: Physicochemical characterization and in vitro dissolution behaviour of its vaginal suppositories. J Incl Phenom Macrocycl Chem. 2011;70:437–45.

    Article  CAS  Google Scholar 

  8. Sinha VR, Nanda A, Kumria R. Cyclodextrins as sustained-release carriers. J Pharm Technol 2002:36–46.

  9. Allen JR, Loyd V. Quality control of suppositories. Suppositories, 1st edition; 2007:139–158.

  10. Yousfan A, Hasian J. Preparation and evaluation of levodropropizine suppositories. J Chem Pharm Res. 2015;7:274–82.

    CAS  Google Scholar 

  11. Ramadan AA. Formulation and evaluation of bioadhesive vaginal suppositories containing miconazole nitrate. J Pharm Bio Sci. 2013;4:455–72.

    CAS  Google Scholar 

  12. Pandey S, Varshney HM, Gupta MM. Effect of adjuvants on the release pattern of suppositories containing paracetamol. J Chem Environ Sci. 2013;1:19–25.

    Google Scholar 

  13. Amiri S, Rahimi A. Self-healing hybrid nanocomposite coatings containing encapsulated organic corrosion inhibitors nanocontainers. J Polym Res 2014, DOI: https://doi.org/10.1007/s10965-014-0624-z.

  14. Amiri S, Rahimi A. Synthesis and characterization of supramolecular corrosion inhibitor nanocontainers for anticorrosion hybrid nanocomposite coatings. J Polym Res. 2015 DOI: https://doi.org/10.1007/s10965-015-0699-1

  15. Amiri S, Rahimi A. Preparation of supramolecular corrosion inhibitor nanocontainers for self-protective hybrid nanocomposite coatings. J Polym Res 2014, DOI: https://doi.org/10.1007/s10965-014-0566-5

  16. Amiri S, Rahimi A. Anticorrosion behavior of cyclodextrins/inhibitor nanocapsule-based self-healing coatings. J Coat Technol Res. 2016;13:1095–102. https://doi.org/10.1007/s11998-016-9824-2.

    Article  CAS  Google Scholar 

  17. Amiri S, Rahimi A. Self-healing anticorrosion coating containing 2-mercaptobenzothiazole and 2-mercaptobenzimidazole nanocapsules. J Polym Res. 2016;23:23–83.

    Article  CAS  Google Scholar 

  18. The United States Pharmacopeia, USP 38, Volume 1, 2015.

  19. Cwiertnia B. Effect of water soluble carrier on dissolution profiles of diclofenac sodium. J Pharm Technol. 2013;70:721–6.

    CAS  Google Scholar 

  20. Gowthamarajan K, Kulkarni TG, Nenkateswaran G, Samanta MK, Suresh B. Formulation and dissolution properties of meloxicam solid dispersion incorporated suppositories. Indian J Pharm Sci. 2002;1:525–8.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sahar Amiri.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asgari, F., Amiri, S. & Ghiass, M. Improve Solubility of Acetamidophenol from PEG and Witepsol Suppositories via Formation of Inclusion Complex by β-Cyclodextrin with a Controlled Release Profile. J Pharm Innov 14, 57–65 (2019). https://doi.org/10.1007/s12247-018-9328-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12247-018-9328-y

Keywords

Navigation